Gelated Apoptotic Extracellular Vesicles via Enzyme-Instructed Self-Assembly with Multifunctional Microcapsule for Targeted Atherosclerosis Therapy
Ontology highlight
ABSTRACT: While current atherosclerosis therapies control lipid levels, they poorly regulate macrophages, key drivers of plaque progression. Apoptotic extracellular vesicles (apoEVs) offer a cell-free approach to modulate macrophage-driven inflammation, but their applications are limited by cargo leakage, structural instability, and off-target effects. Herein, we developed engineered apoEVs by combining enzyme-instructed self-assembly (EISA) and surface modification techniques. The hydrogel core formed within apoEVs via EISA enabled efficient encapsulation of atorvastatin while also improving vesicle stability. Concurrently, ROS/pH-responsive degradable microcapsules decorated on the apoEV surface enhanced plaque accumulation through hitchhiking and active targeting via the hyaluronic acid-CD44 interaction. Our engineered apoEVs demonstrated potent anti-atherosclerosis effects both in vitro and in vivo by inhibiting foam cell formation, inducing macrophage repolarization, restoring mitochondrial functions, and improving fibrous cap stability. These therapeutic outcomes were further validated using single-cell transcriptomics and multiplex imaging. This study presents a universal and nondestructive strategy for apoEV engineering and highlights its potential for atherosclerosis therapy.
ORGANISM(S): Mus musculus
PROVIDER: GSE343400 | GEO | 2026/08/12
REPOSITORIES: GEO
ACCESS DATA